Clinical Trials Logo

Uremia clinical trials

View clinical trials related to Uremia.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06249373 Not yet recruiting - Uremia; Chronic Clinical Trials

The Effect of LIPUS on the Maturation of Newly Constructed Autogenous AVF

Start date: February 18, 2024
Phase: N/A
Study type: Interventional

This study aims to evaluate the effect of 12 week low-intensity pulse ultrasound (LIPUS) intervention on the maturation of newly constructed autologous arteriovenous fistulas in uremic patients. This study is a prospective, blinded, randomized controlled trial. This trial is divided into two stages. The first stage is a concept validation trial, which is a single center, prospective, blinded, randomized controlled clinical study. Subjects who meet the screening criteria are randomly divided into an intervention group and a control group in a 1:1 ratio. All subjects underwent safety and efficacy evaluations at the 2nd, 4th, 8th, 12th, and 4th week after treatment. After completing a 4-week follow-up of the 20th study subject, an analysis was conducted with the preset goal of achieving a higher maturation rate of arteriovenous fistula in the intervention group compared to the control group at the follow-up point, and the safety of the study was evaluated. The second stage is a key trial, which is a multicenter, prospective, blinded, randomized controlled clinical study. The inclusion criteria, primary and secondary endpoints, and safety endpoints of the study subjects remain unchanged, and the safety and efficacy of the overall population are evaluated.

NCT ID: NCT06233838 Not yet recruiting - Uremia Clinical Trials

Multi-center Clinical Study on Hemoperfusion of KHA80

Start date: February 1, 2024
Phase: N/A
Study type: Interventional

To evaluate the decreasing rate of blood IL-6, β2-MG and PTH in maintenance hemodialysis patients in the 52nd week compared with routine hemodialysis.

NCT ID: NCT05386433 Not yet recruiting - COVID-19 Clinical Trials

Paxlovid in the Treatment of COVID-19 Patients With Uremia

Start date: June 2022
Phase: Early Phase 1
Study type: Interventional

This study is a single-center, open-label, randomized controlled clinical study to evaluate the effect of Paxlovid on the virus-negative time and disease progression in uremic patients infected with SARS-CoV-2 (omicron variants). This study will enroll maintenance hemodialysis patients infected with SARS-CoV-2 (omicron variants). After signing the informed consent form, the qualified subjects will be randomly stratified 1:1 to standard-of-care (SOC) or SOC plus Paxlovid for five days.

NCT ID: NCT02266238 Not yet recruiting - Clinical trials for Arteriovenous Fistula

Stenosis of Arteria-Venous Fistula in Maintenance Hemodialysis Patients: Early Intervention Trial

SAVEIT
Start date: January 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the effect of DSA guided percutaneous balloon dilatation, ultrasound guided percutaneous balloon dilatation and surgical repair in the treatment of Stenosis of Arteria-Venous Fistula in Maintenance Hemodialysis Patients.

NCT ID: NCT00577967 Not yet recruiting - Pruritus Clinical Trials

Gabapentin - A Solution to Uremic Pruritus?

Start date: October 2005
Phase: N/A
Study type: Interventional

To investigate using the drug gabapentin to relieve the intense pruritic sensation associated with chronic renal failure patients undergoing peritoneal dialysis.